The Conversation (0)
BioAmber (OTCP:BIOA) has announced that the Toronto Stock Exchange (TSX) has notified the company that it will suspend the company’s trading of shares of common stock effective February 16 and to delist the company’s securities effective at market close on March 16. As quoted in the press release: These measures were taken due to the …
BioAmber (OTCP:BIOA) has announced that the Toronto Stock Exchange (TSX) has notified the company that it will suspend the company’s trading of shares of common stock effective February 16 and to delist the company’s securities effective at market close on March 16.
As quoted in the press release:
These measures were taken due to the Company not meeting the continued listing requirements of the TSX. Notification by the TSX of expedited listing review was announced on February 13, 2018.
The Company’s shares currently trade on the OTC Pink Sheets. The TSX notification does not affect the Company’s business operations or its Securities and Exchange Commission (“SEC”) or applicable Canadian reporting requirements, and does not constitute an event of default under any of the Company’s debt obligations.
